FDA Inspection 1258246 — Mary Bird Perkins Cancer Center
The FDA completed an inspection of Mary Bird Perkins Cancer Center on Dec 17, 2024 in Baton Rouge, LA. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Biologics.
Inspection details
- Classification
- No Action Indicated (NAI)
- End Date
- Dec 17, 2024
- Fiscal Year
- 2025
- Product Type
- Biologics
- Project Area
- Blood and Blood Products
- Location
- Baton Rouge, LA (United States)